The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05047094
Recruitment Status : Recruiting
First Posted : September 16, 2021
Last Update Posted : May 20, 2024
Information provided by (Responsible Party):
Alpha Tau Medical LTD.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2026
Estimated Study Completion Date : June 2027